THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH
Patent Owner
Stats
- 16 US PATENTS IN FORCE
- 4 US APPLICATIONS PENDING
- Feb 27, 2018 most recent publication
Details
- 16 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 505 Total Citation Count
- May 22, 1992 Earliest Filing
- 34 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0107,577 Determining Cancer Aggressiveness, Prognosis and Responsiveness to TreatmentMar 11, 15Apr 20, 17[C12Q, G01N, C07K]
2016/0208,000 IMMUNORECEPTOR MODULATION FOR TREATING CANCER AND VIRAL INFECTIONSAug 22, 14Jul 21, 16[A61K, C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8986700 Immunogenic lipopeptides comprising T-helper and cytotoxic T-lymphocyte (CTL) epitopesOct 08, 10Mar 24, 15[A61K, C07K]
7833532 Immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopesAug 12, 03Nov 16, 10[A61K]
7524503 Human cytomegalovirus (HCMV) cytotoxic T cell epitopes, polyepitopes compositions comprising same and diagnostic and prophylactic and therapeutic uses thereforJun 26, 02Apr 28, 09[A61K, C12Q, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0200,814 IMMUNORECEPTOR MODULATION FOR TREATING CANCER AND VIRAL INFECTIONSAbandonedOct 03, 13Jul 14, 16[A61K, G01N, C07K]
8367067 Immunogenic lipopeptides comprising T-helper and B-cell epitopesExpiredJun 19, 09Feb 05, 13[A61K]
8206725 Immunogenic agent and pharmaceutical composition for use against homologous and heterologous pathogens including plasmodium SPPExpiredJun 30, 04Jun 26, 12[A61K, A01N]
2011/0158,998 HELMINTH ANTIGEN AND IMMUNOTHERAPYAbandonedJun 09, 06Jun 30, 11[A61K, C12P, C12N, G01N, A61P, C07K]
2011/0064,745 Therapeutic Antibodies, Antibody Fragments And Antibody ConjugatesAbandonedAug 23, 10Mar 17, 11[A61K, A61P, C07K]
2010/0297,623 NOVEL HUMAN ssDNA BINDING PROTEINS AND METHODS OF CANCER DIAGNOSISAbandonedMar 07, 08Nov 25, 10[C07H, C12Q, G01N, C07K]
2010/0183,647 Novel human cytomegalovirus (HCMV) cytotoxic T cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses thereforAbandonedMar 16, 09Jul 22, 10[A61K, C12Q, C12N, A61P, C07K]
2009/0304,660 G-CSF DERIVATIVE FOR INDUCING IMMUNOLOGICAL TOLERANCEAbandonedAug 20, 09Dec 10, 09[A61K, C12P, C12N]
7569225 Immunogenic lipopeptides comprising T-helper and B-cell epitopesExpiredAug 12, 03Aug 04, 09[A61K]
2009/0010,929 Therapeutic Antibodies, Antibody Fragments and Antibody ConjugatesAbandonedDec 04, 07Jan 08, 09[A61K, A61P]
2007/0048,329 Epstein barr virus peptide epitopes, polyepitopes and delivery system thereforAbandonedNov 03, 03Mar 01, 07[A61K, C07H, C12Q, C12P, C07K]
2007/0041,937 G-csf derivative for inducing immunological toleranceAbandonedAug 20, 04Feb 22, 07[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.